Objective: The objective was to evaluate the association between sarcopenia (EWGSOP) and osteoporosis in older adults. Subjects and methods: This is a cross sectional analysis of a baseline evaluation of the SARCopenia and OSteoporosis in Older Adults with Cardiovascular Diseases Study (SARCOS). Three hundred and thirty-two subjects over 65 years of age were evaluated. Sarcopenia was determined by EWGSOP flowchart and Osteoporosis was established by WHO's criteria. Physical function, comorbidities and medications were evaluated. Results: Women were older (79.8 ± 7.2 years) than men (78.21 ± 6.7 years) (p = 0.042). Osteoporosis occurred in 24.8% of men, and in 42.7% of women (p < 0.001); sarcopenia occurred in 25.5% of men and in 17. 
INTRODUCTION

S
arcopenia and osteoporosis are musculoskeletal clinical syndromes related to ageing, and are major public health concerns due to their likely bad outcomes. While the loss of bone mass increases the risk of fractures, loss of muscle mass and strength are strongly associated with a higher chance of falls (1, 2) . In turn, falls and fractures may lead to immobilization and a decrease in physical activity and these raise the odds of disability, hospitalization and the need for inpatient rehabilitation (3, 4) .
Studies have demonstrated the correlation between low muscle mass and muscle strength and low bone mineral density in postmenopausal women (5) but not in men (6) . However, the effect of bone on muscle mass and muscle strength has also been documented.
Juffer and cols. (7) has shown that osteocytes stimulated by mechanostatic action produce a number of factors, such as IGF-I, MGF, VEGF, and HGF which stimulate muscular function and formation. More recently, Yoshimura and cols. (8) showed that osteoporosis predicts incidental sarcopenia by the Asian Work Group for Sarcopenia (AWGS) in 4 years, but contrary to expectations, the opposite relationship was not significant. These results presented great variation due to the diverse concepts of sarcopenia, as well as due to uncontrolled variables that do not permit the establishment of a clear association between sarcopenia and osteoporosis with old age and gender. Based on these findings, we hypothesized that sarcopenia, by EWGSOP (European Working Group on Sarcopenia in Older People), has a strong association with osteoporosis in older females but not in older males; additionally, we believe that the inverse association, i.e. osteoporosis with sarcopenia by EWGSOP will show the same trend in both sexes. To test our hypothesis, we evaluated the association between osteoporosis according to the WHO's definition (9) and sarcopenia according to the EWGSOP (10) in older men and women from the same population group, with established risk factors and significant variables that could interfere with bone mineral density, muscle mass and muscle strength.
SUBJECTS AND METHODS
Subjects
This study is a cross sectional analysis of a baseline evaluation of the SARCopenia and OSteoporosis in Older Adults with Cardiovascular Diseases Study (SARCOS), a one-year prospective cohort study that investigated the association between cardiovascular diseases and changes in body composition, muscle strength and physical performance as a common pathway to disability. We interviewed 383 older outpatient adults from an outpatient cardio-geriatric clinic and 332 were included in this study and underwent DXA analyzes.
Our population was composed by older adults, over 65 years of age, both sexes and all ethnic groups. Exclusion criteria were: unstable medical conditions, any form of cancer in the last five years, chronic renal failure in dialysis, Parkinson's disease, severe infectious disease requiring hospitalization in the previous month, moderate or severe dementia classified by the MMSE (mini-mental state examination) (11, 12) and use of gait assistant devices. This study was approved by the Ethical Review Board at our Institution and written informed consent was obtained from all participants.
Diagnosis of sarcopenia
Sarcopenia, as determined by EWGSOP's flowchart (10) , is defined by the presence of weakness represented by grip strength of the dominant hand lower than 20 kgf for women and 30 kgf for men and/or a gait speed lower than 0.8 m/s, plus low appendicular muscle mass by height 2 lower than 5.45 kg/m 2 for women and 7.26 kg/m 2 for men.
Handgrip strength
Isometric grip strength of the dominant upper extremity was determined by three measurements with a handheld dynamometer (Jamar; TEC, Clifton, NJ, USA); maximum values are reported.
Bone mineral density and osteoporosis
Bone mineral density (BMD -g/cm 2 ) of the lumbar spine, femoral neck, total femur and appendicular muscle mass and total fat mass were assessed through a DXA analysis by dual-energy X-ray absorptiometry (GE Lunar; DPX-MD 73477, GE Medical system, Madison, WI). Osteoporosis was established by the WHO's criteria (9) , i.e., BMD T score ≤ -2.5 standard deviations (SD) at lumbar spine, femur neck, and total femur.
Disability
Disability was assessed by the number of tasks performed in activities of daily living (ADL) and instrumental activities of daily living (IADL); the cut point for disability was 5 for ADL or 25 for IADL (13) (14) (15) .
Other measurements
Demographic data, weight, height, cardiovascular disease (arterial hypertension, atrial fibrillation, previous myocardial infarction, chronic atherosclerosis coronary, heart failure, peripheral arterial obstruction) and other chronic diseases: diabetes mellitus osteoarthritis, nondialysis dependent chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), previous diagnosis of cancer, current or previous consumption of alcohol (at least one year without drinking alcohol), and current or previous smoking history (at least five years without smoking). We also considered falls (at least one fall in last 6 months) and history of fractures (a clinical fracture or diagnosed by radiograph assessment in a Health Care service). Finally, we evaluated all medications that could interfere in bone and muscle metabolism, such as bisphosphonates, tereparatide, strontium ranelate, corticosteroids in high doses (≥ 7.5 mg predinisone/day or equivalent for more than 3 months), vitamin D over 800 IU/ day, estrogen and progesterone replacements, ACE (angiotensin-converting-enzyme) inhibitors, ARB (angiotensin II receptor blocker) I and II inhibitors.
Statistical analysis
Qualitative variables are expressed as absolute and relative frequencies. Quantitative data are summarized as means, medians, standard deviations, minimum and maximum values. To compare the groups (sarcopenia and osteoporosis) the chi-square test for qualitative variables and ANOVA for quantitative variables were used to compare differences in baseline characteristics by gender.
Binomial logistic regression analyses were performed to evaluate the association between osteoporosis (OP) with sarcopenia EWGSOP and vice versa. Adjusted regression analyses were performed with significant variables for sarcopenia (current use of ACE inhibitor/ ARB I and II inhibitors, falls, previous fracture (only for women), diabetes mellitus and disability), and for osteoporosis (falls, age, previous alcohol consumption, disability, smoking history, bisphosphonate use and diabetes mellitus). In the case of two quantitative variables, scatter diagrams and correlation coefficients were used. SPSS version 22 (SPSS, Inc., Chicago, IL, USA) statistical software package was used for carrying out all the analyses. Statistical significance was set at 0.05.
RESULTS
Demographic data, body composition parameters, muscle strength, prevalence of chronic and cardiovascular diseases, osteoporosis, and sarcopenia are described in Table 1 . Prevalence of osteoporosis and sarcopenia
The characteristics of the older adults with and without osteoporosis and sarcopenia are shown in Tables 2 and 3 .
The association of osteoporosis and sarcopenia EWGSOP in older men and women Osteoporosis was diagnosed in 52.5% (n = 32; p = 0.002) of subjects with sarcopenia, but sarcopenia was only diagnosed in 27.4% of subjects with osteoporosis. This trend was observed in women, where 68% of sarcopenic patients showed osteoporosis, and only 20.7% (n = 17; p = 0.009) of osteoporotic patients showed sarcopenia; contrary to this, 44.7% of men with sarcopenia presented with osteoporosis and 42.9%; (n = 15; p = 0.013) of men with osteoporosis presented with sarcopenia. Both disorders occurred in 10.6% of men and 8.9% of women.
In the logistic regression analyses for sarcopenia, osteoporosis presented a similar value of the association for men OR=3.03 (95% CI: 1.334-6.909; p = 0.008) and women OR = 3.30 (95%CI: 1.347-8.091; p = 0.009), and vice versa. In the adjusted logistic regression analyses, for sarcopenia and osteoporosis, we used different variables for, for men and women, according to statistical significance that they had presented previously (Tables 2 and 3 ). Variables used in Table 2 . Demographic data and prevalence of chronic and cardiovascular diseases, in men and women with and without osteoporosis (Table 4) . Interestingly, contrary to the previous literature (10, 16, 17) , age was not an independent predictor of osteoporosis and sarcopenia, in both sexes. Diabetes mellitus was negatively associated with osteoporosis in men, but in women this association was found to be inverse and also significant ( Table 4) . Disability showed the highest association with sarcopenia in both genders in comparison with the other variables. Finally, in women, previous fractures were also associated with sarcopenia (Table 4) . ).
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DISCUSSION
To the best of our knowledge, this is the first study to demonstrate that there are important differences in the association between sarcopenia EWGSOP and osteoporosis in older adults determined by sex. Contrary to our hypothesis, females did have an association between osteoporosis and sarcopenia EWGSOP; however, this association did not remain relevant after adjustments for confounder clinical variables were performed. Previous studies (18, 19) on the relationship between loss of muscle mass and strength and osteoporosis have shown great variation according to sex, age and health, diagnostic criteria for sarcopenia and cutoff points used for bone loss; these factors may cause a significant variation in the association values. One of the few studies that used the EWGSOP's criteria analyzed 409 independent women, aged 70-80 years from the community, and did not find a significant association between low BMD and sarcopenia (20) although the prevalence of sarcopenia by EWGSOP was very low (0.9%) and only 36% of those women presented with osteopenia.
Our findings in women differ significantly from others, but the population, the definition of sarcopenia, and confounder variables evaluated were different. In the Osteoporosis Risk Factor and Prevention (OSTPRE) Study, women with sarcopenia by EWGSOP had 12.9 times (3.1-53.5; p < 0.001) higher odds of having osteoporosis when compared to women without sarcopenia; but in the OSTPRE study the sample was composed by younger (68.7 ± 1.8 yo) postmenopausal women from the dwelling community. Besides, in our outpatient population, sarcopenia diagnosis was made with a higher cut off for lean mass (cut-off of 6.3 kg/m 2 ) (21). Another key point of our data was the diversity in the correlation between diabetes and osteoporosis among the sexes. In older women, the presence of diabetes has shown a higher risk of osteoporosis, whereas in men it appears to have a protective effect. However, these results should be evaluated with caution, since the study was not designed for this purpose. Higher levels of BMD in men with diabetes compared to non-diabetes subjects were also described in the Rotterdam, EVOS and The Health ABC studies; they have demonstrated 3-5% higher bone site BMD in men with diabetes vs. nondiabetes (22) (23) (24) .
The greater tendency of osteoporosis in women, evidenced in our series and also present in other studies, may be justified by the earlier estrogenic deprivation caused by menopause, by the other hormone deficiencies, more comorbidities (25, 26) , and by the process of inflammaging (27) . In men, osteoporosis usually begins during the seventh decade (28) justifying the difference in prevalence between sexes due to the decrease of testosterone. Estrogen deprivation, also affects the incidence of sarcopenia, but mainly by the loss of muscle strength (29) . This theory is endorsed by studies noting that muscle strength is preserved in women who opt for hormone replacement therapy at the onset of menopause, as compared with those who do not (30) .
We believe that screening for osteoporosis in older adult outpatients should be recommended not only to evaluate the risk of fractures through the analysis of BMD but additionally, to evaluate the risk of sarcopenia, an important risk factor for falls and fractures. This strong association between osteoporosis and sarcopenia, and vice versa, especially in older men, must be considered when deciding upon therapeutic strategies for the prevention of fractures, since it is of utmost importance that both conditions are treated. This study has limitations. First, our sample size is small, although it is considerable if we concede that it is a very old population (average age 80 yo). Another limitation of our study was the non-radiological confirmation of bone fractures of the majority of patients who reported a history of fracture, which may cause a bias on the analyses of the osteoporotic sample, since previous fractures should be considered as having osteoporosis, independent of DXA. Also, as the average age is high, we cannot extrapolate our findings to a younger population. This study is a cross sectional analyses and, as such, does not allow us to establish a cause and effect relationship between the loss of BMD and the loss of appendicular muscle mass and/or muscle strength. We did not quantify myokines that could help shed some light on the interaction between loss of bone and muscle mass/strength.
In summary, older adults from an outpatient clinic setting presented with a high prevalence of osteoporosis and/or sarcopenia EWGSOP. In regards to sex, sarcopenia EWGSOP was more prevalent in males while osteoporosis was more prevalent in females. The interaction between muscle mass and muscle function with bone metabolism seems to be more intense in older men than in older women. In conclusion, according to sex, there are significant differences in the association between sarcopenia EWGSOP and osteoporosis in outpatient older adults. It is strong and significant in males; in females, despite showing a positive trend, it was not statistically significant.
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